|
|
|
|
|
|
Ptc Therapeutics (PTCT)
|
|
18.54 -0.49 (-2.57%)
|
8/23/2017 2:58pm
|
|
Open:
|
18.84
|
Pre. Close:
|
19.03
|
|
High:
|
19.20
|
Low:
|
18.43
|
|
Volume:
|
240,024
|
Market Cap:
|
765.78M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
19.2 - 19.53
|
19.53 - 20.01
|
|
Low:
|
16.85 - 17.16
|
17.16 - 17.61
|
|
Close:
|
18.18 - 18.78
|
18.78 - 19.65
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-23 2:38:47 PM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 23.31 One year: 25.52
|
|
Support:
|
Support1: 16.90 Support2: 14.06
|
|
Resistance:
|
Resistance1:
19.96 Resistance2: 21.85
|
|
Pivot:
|
18.63
|
|
Moving Averages:
|
MA(5): 18.10  MA(20): 19.00
MA(100): 15.65 MA(250): 12.86
|
|
MACD:
|
MACD(12,26):
-0.25 Signal(12,26,9): -0.13
|
|
%K %D:
|
%K(14,3): 38.92 %D(3): 27.40
|
|
RSI:
|
RSI(14): 49.53
|
|
52-Week:
|
High: 21.85
Low: 4.03 Change(%): 135.9
|
|
Average Vol(K):
|
3-Month: 65637
10-Days 11770
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.PTCT has closed below upper band by 47.6%. Bollinger Bands are 2.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Sat, 08 Jul 2017 10:41:15 GMT
Here's Why PTC Therapeutics, Inc. Popped 45.2% in June
Mon, 08 May 2017 13:25:06 GMT
CORRECTED: PTC Therapeutics' DMD drug Emflaza to cost $35000 a year and launch ...
Tue, 22 Aug 2017 21:30:06 GMT
PTC Therapeutics Inc. (PTCT) Soars 7.39% on August 22
Wed, 28 Jun 2017 13:41:15 GMT
PTC Therapeutics Shows Strong Potential Ahead Of Ultra-Orphan-Drug Launch
Thu, 16 Mar 2017 11:15:00 GMT
PTC Therapeutics Announces Agreement to Acquire Emflaza™ for the Treatment of ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
